| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_DLGAP4_0003100 | Intron-Intron | chr20:35092873-35105331 | chr20:36464470-36476928 | 250 nt | 0.3960 |
| hsa_DLGAP4_0003400 | Intron-Intron | chr20:35093668-35103322 | chr20:36465265-36474919 | 250 nt | 0.4360 |
| hsa_DLGAP4_0003500 | Intron-Exon-Intron | chr20:35093668-35125469 | chr20:36465265-36497066 | 465 nt | 0.5892 |
| hsa_DLGAP4_0003600 | Intron-Exon | chr20:35093668-35128678 | chr20:36465265-36500275 | 711 nt | 0.5837 |
| hsa_chr20_0113400 | Intergenic-Intergenic | chr20:35097128-35097663 | chr20:36468725-36469260 | 536 nt | 0.4030 |
| hsa_chr20_0113500 | Intergenic-Intergenic | chr20:35099931-35102412 | chr20:36471528-36474009 | 116 nt | 0.5000 |
| hsa_chr20_0113600 | Intergenic-Intergenic | chr20:35101645-35102412 | chr20:36473242-36474009 | 328 nt | 0.4939 |
| hsa_DLGAP4_0003700 | Intron-Intron | chr20:35112397-35112601 | chr20:36483994-36484198 | 205 nt | 0.4976 |
| hsa_chr20_0113700 | Intergenic-Intergenic | chr20:35112711-35112955 | chr20:36484308-36484552 | 245 nt | 0.5959 |
| hsa_chr20_0113800 | Intergenic-Intergenic | chr20:35117575-35118027 | chr20:36489172-36489624 | 453 nt | 0.4658 |
A study in mice and humans demonstrated that the circDLGAP4 is significantly decreased in plasma after acute ischemic stroke and in a mouse stroke model, suggesting its potential as a therapeutic target for myocardial ischemia/reperfusion injury [Tian et al. DOI:10.3390/molecules26041155].